A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.
about
Receptor-binding domain-based subunit vaccines against MERS-CoVAdvancements in the development of subunit influenza vaccinesCurrent advancements and potential strategies in the development of MERS-CoV vaccinesYeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate.Intranasal vaccination with recombinant receptor-binding domain of MERS-CoV spike protein induces much stronger local mucosal immune responses than subcutaneous immunization: Implication for designing novel mucosal MERS vaccines.Identification of an ideal adjuvant for receptor-binding domain-based subunit vaccines against Middle East respiratory syndrome coronavirus.Recombinant Hemagglutinin and Virus-Like Particle Vaccines for H7N9 Influenza VirusReceptor-binding domain of MERS-CoV with optimal immunogen dosage and immunization interval protects human transgenic mice from MERS-CoV infection.Identification of a receptor-binding domain in the S protein of the novel human coronavirus Middle East respiratory syndrome coronavirus as an essential target for vaccine development.A conformation-dependent neutralizing monoclonal antibody specifically targeting receptor-binding domain in Middle East respiratory syndrome coronavirus spike protein.Searching for an ideal vaccine candidate among different MERS coronavirus receptor-binding fragments--the importance of immunofocusing in subunit vaccine design.A truncated receptor-binding domain of MERS-CoV spike protein potently inhibits MERS-CoV infection and induces strong neutralizing antibody responses: implication for developing therapeutics and vaccinesOptimization of antigen dose for a receptor-binding domain-based subunit vaccine against MERS coronavirus.Respiratory nanoparticle-based vaccines and challenges associated with animal models and translationA safe and convenient pseudovirus-based inhibition assay to detect neutralizing antibodies and screen for viral entry inhibitors against the novel human coronavirus MERS-CoVHighly pathogenic avian influenza A(H5N1) mutants transmissible by air are susceptible to human and animal neutralizing antibodiesIntranasal vaccination of recombinant H5N1 HA1 proteins fused with foldon and Fc induces strong mucosal immune responses with neutralizing activity: Implication for developing novel mucosal influenza vaccines.Recombinant Lactococcus lactis Expressing Haemagglutinin from a Polish Avian H5N1 Isolate and Its Immunological Effect in Preliminary Animal Trials.A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection.Nanodiamond enhances immune responses in mice against recombinant HA/H7N9 protein.Influenza Viral Vectors Expressing Two Kinds of HA Proteins as Bivalent Vaccine Against Highly Pathogenic Avian Influenza Viruses of Clade 2.3.4.4 H5 and H7N9.
P2860
Q26851979-16D82599-0EBD-4437-8ACC-ACAAAE5A806BQ27010100-DC71680C-B804-4286-8D21-DD997CD5971FQ27012578-348BAECC-5523-4679-9E9E-D03C2835F638Q30218075-C6B95940-868F-4D01-8B52-4085A53F83D1Q30359335-6A0A5A57-A722-468B-A9E0-5E53A3851BD8Q30371303-FB1A1DF8-2DC4-4D9E-A43E-C1D99F4F492CQ30380945-2ADFEF21-1086-4C23-90F2-B0A2D98F9B07Q30399700-B9F8A832-D403-48CF-9569-C77FC6E0EBFCQ30432706-B0EBE3DE-5DF6-42A7-9524-40783D2DCFAAQ33743790-973B1303-121C-40A8-BEDB-4E1167A2B94DQ34324907-5400EAA2-CD68-4721-95A0-BEB14EAFE2C8Q35063993-0140ECD4-106E-4347-BF8A-D18FBA44F719Q35887626-0EF7D813-1FE4-4744-AC97-3AF923D227D7Q36598433-3DCFD7D7-8478-4F0A-90EA-9C3E578B9476Q37152873-698E8C19-AFC3-4745-8237-522899806616Q37187514-60E62B6E-1DAF-4660-9BB0-3E2C5234ECB1Q37320159-8D7C3E5B-7938-4C94-85F4-ED23FCB9B6F8Q40283850-BBDAC430-F0C7-4F43-9347-EBFAB8DF9400Q40503787-5CB349E9-159E-46F7-B3C7-4CBB2232F26DQ41923429-2D905D3C-B677-42D8-8260-9BF0C1F902ABQ53829188-E0CB07F1-FD3D-4D39-9273-99AB5E8D3CD2
P2860
A critical HA1 neutralizing domain of H5N1 influenza in an optimal conformation induces strong cross-protection.
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A critical HA1 neutralizing do ...... duces strong cross-protection.
@ast
A critical HA1 neutralizing do ...... duces strong cross-protection.
@en
A critical HA1 neutralizing do ...... duces strong cross-protection.
@nl
type
label
A critical HA1 neutralizing do ...... duces strong cross-protection.
@ast
A critical HA1 neutralizing do ...... duces strong cross-protection.
@en
A critical HA1 neutralizing do ...... duces strong cross-protection.
@nl
prefLabel
A critical HA1 neutralizing do ...... duces strong cross-protection.
@ast
A critical HA1 neutralizing do ...... duces strong cross-protection.
@en
A critical HA1 neutralizing do ...... duces strong cross-protection.
@nl
P2093
P2860
P1433
P1476
A critical HA1 neutralizing do ...... duces strong cross-protection.
@en
P2093
Guangyu Zhao
Shihui Sun
Xiaojun Zhou
Xiujuan Zhang
Yusen Zhou
P2860
P304
P356
10.1371/JOURNAL.PONE.0053568
P407
P577
2013-01-08T00:00:00Z